Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.31 EUR | -2.12% | -4.94% | -25.96% |
04-23 | Maps, to group company project from Novara Health Authority | AN |
03-28 | Futures tentatively up, eyes on macros | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 12.49 for the current year.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-25.96% | 30.82M | - | ||
-13.45% | 191B | A- | ||
+1.32% | 167B | B+ | ||
+1.32% | 152B | B- | ||
+3.83% | 99.13B | A- | ||
+7.97% | 78.79B | A- | ||
+21.50% | 75.03B | C- | ||
-8.21% | 70.51B | A | ||
-19.94% | 53.21B | C | ||
-8.05% | 43.78B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MAPS Stock
- Ratings Maps S.p.A.